Literature DB >> 33092967

High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma(cT1N0).

Bin Zhou1, Jianwu Qin2.   

Abstract

OBJECTIVE: The incidence of papillary thyroid carcinoma (PTC) increases yearly. Central lymph node metastasis (CLNM) is common in PTC. Many studies have addressed ipsilateral CLNM; however, few studies have evaluated contralateral CLNM. The purpose of this study is to investigate the high-risk factors of lymph node metastasis in the contralateral central compartment of cT1 stage in PTC.
METHODS: In total, 369 unilateral PTC (cT1N0) patients who underwent total-thyroidectomy with bilateral central lymph node dissection (CLND) between 2013 and 2016 in our hospital were retrospectively enrolled. Univariate and multivariate analyses identified the high-risk factors for contralateral CLNM of PTC.
RESULTS: The total metastasis rate of the ipsilateral central neck compartment was 31.71% (117/369). The total metastasis rate of the contralateral central neck compartment was 8.13% (30/369). The multivariate analysis showed that multifocality (p = 0.009), ipsilateral CLNM (p<0.001), number of ipsilateral CLNM >2 (p = 0.006), tumor located at the inferior pole (p = 0.032) and tumor diameter > 1 cm (p = 0.029) were independent risk factors for contralateral CLNM at cT1 stage in PTC, with odds ratios (ORs) of,4.132 (95% confidence intervals (CI): 1.430-11.936) ,8.591 (95% CI: 3.200-23.061) ,0.174 (95% CI: 0.050-0.601) ,0.353 (95% CI: 0.136-0.917)and 0.235 (95% CI: 0.064-0863), respectively.
CONCLUSION: The combinational use of these risk factors will help surgeons devise an appropriate surgical plan preoperatively. This information could provide reference for the readers who are interested and help to determine the optimal extent of CLND in patients with PTC, especially for cT1b patients.
Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Central lymph node metastasis; Clinically node negative; Contralateral central compartment; Papillary thyroid carcinoma; Risk factors

Year:  2020        PMID: 33092967     DOI: 10.1016/j.ejso.2020.10.018

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.

Authors:  Yin-Zhu Zhao; Nian-An He; Xian-Jun Ye; Fu Jin; Meng-Xue Li; Xianxian Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

2.  A Mathematical Model to Assess the Effect of Residual Positive Lymph Nodes on the Survival of Patients With Papillary Thyroid Microcarcinoma.

Authors:  Wen Liu; Xuejing Yan; Zhizhong Dong; Yanjun Su; Yunhai Ma; Jianming Zhang; Chang Diao; Jun Qian; Tao Ran; Ruochuan Cheng
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

3.  Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience.

Authors:  Bin Zeng; Yu Min; Yang Feng; Ke Xiang; Hang Chen; Zijing Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-20       Impact factor: 6.055

4.  Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.

Authors:  Y Feng; Y Min; H Chen; K Xiang; X Wang; G Yin
Journal:  J Endocrinol Invest       Date:  2021-02-14       Impact factor: 4.256

5.  Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.

Authors:  Qungang Chang; Jieming Zhang; Yaqian Wang; Hongqiang Li; Xin Du; Daohong Zuo; Detao Yin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-15       Impact factor: 6.055

6.  Effect of Tumor Location on the Risk of Bilateral Central Lymph Node Metastasis in Unilateral 1-4 cm Papillary Thyroid Carcinoma.

Authors:  Nan Liu; Bo Chen; Luchuan Li; Qingdong Zeng; Lei Sheng; Bin Zhang; Bin Lv
Journal:  Cancer Manag Res       Date:  2021-07-20       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.